New Deal With Pharmaceuticals Firm to Help Hospital Treat Rare Diseases - Cincinnati Children's Blog

New Deal With Pharmaceuticals Firm to Help Hospital Treat Rare Diseases

Cincinnati Children’s has negotiated a deal with pharmaceuticals firm Shire Plc to develop drugs to treat rare diseases.

“We are very excited to partner with Shire in this capacity as we strive to change the outcome for children with rare and complex diseases,” said Dr. Margaret Hostetter, chief medical officer of Cincinnati Children’s and director of the research foundation. “Cincinnati Children’s full spectrum of research capabilities – basic, clinical and translational – coupled with Shire’s drug-development expertise makes for a very powerful partnership that we hope will have an impact on patients around the world.”

The Cincinnati Business Courier has the full story on the new deal at its website.

Subscribe today for more stories, tips and updates.

Cincinnati Children’s News Team

About the Author:

The members of the news team at Cincinnati Children's are responsible for telling the stories of the medical center. Stories of the families we serve, research and clinical care, safe and healthy practices and happenings at the hospital. If it has to do with Cincinnati Children's, Danielle, Nick, Jim, Kate, Rachel, Terry and Shannon will keep you informed.

Write a comment

Comments

No Comments Yet! You can be first to comment on this post!